Skip to content

Peripheral RotablatorPRO Post-Marketing Database Study

Peripheral RotablatorPRO Post-Marketing Database Study - Peripheral RotablatorPRO Post-Marketing Database Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060755
Enrollment
50
Registered
2026-03-02
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic limb-threatening ischemia

Interventions

None listed

Sponsors

Boston Scientific Japan K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients intended to be treated with Peripheral RotablatorPRO

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
The incidence of adverse events related to the use of the device and angiographic events, including vascular dissection, vessel perforation, and distal embolization, will be evaluated. In addition, the incidence of device malfunction events, including guidewire fracture, retained guidewire, difficulty in guidewire removal, and difficulty in burr removal, will be evaluated.

Countries

Japan

Contacts

Public ContactHiroshi Sakamoto

Boston Scientific Japan K.K. Clinical Affairs

Hiroshi.Sakamoto@bsci.com03-6853-7500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026